Reston, VA—A new imaging agent, 68Ga-ABY-025, can predict early metabolic response to human epidermal growth factor receptor 2 (HER2)-targeted treatment in ...
Reston, VA—In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid in therapy selection without ...
Reston, VA—In prostate cancer patients experiencing recurrence following a radical prostatectomy, imaging with 18F-DCFPyL PSMA PET/CT has been shown to considerably ...
Vancouver, British Columbia, Canada (Embargoed until 3:00 p.m. PDT, Sunday, June 12, 2022)—A novel artificial intelligence method can be used ...
Reston, VA—By combining information from two advanced imaging techniques with clinical data, physicians can improve their prediction of heart attacks, ...
